ULTRASTRUCTURAL CHANGES IN THE LIVER IN EXPERIMENTAL HYPERHOMOCYSTEINEMIA ON THE BACKGROUND OF HYPO- AND HYPERTHYROIDISM

Authors

  • V. M. Nechiporuk M. Pyrohov Vinnytsia National Medical University
  • Z. M. Nebesna I. Horbachevsky Ternopil National Medical University
  • О. V. Kovalchuk M. Pyrohov Vinnytsia National Medical University
  • L. O. Pentiuk M. Pyrohov Vinnytsia National Medical University
  • M. M. Korda I. Horbachevsky Ternopil National Medical University

DOI:

https://doi.org/10.11603/bmbr.2706-6290.2021.2.12339

Keywords:

hyperthyroidism, hypothyroidism, hyperhomocysteinemia, homocysteine, liver

Abstract

Summary. Thyroid hormones play a crucial role in maintaining metabolic homeostasis throughout life. It is well known that the liver and thyroid gland are closely related, with thyroid hormones playing an important role in de novo lipogenesis, beta-oxidation of fatty acids, cholesterol metabolism and carbohydrate metabolism. High levels of circulating homocysteine ​​(HC) (hyperhomocysteinemia (HHC)) are an independent factor in the development of atherosclerosis, induce the completion of the cell cycle, accelerate the aging process, cause apoptosis in endothelial cells and neurons.

The aim of the study – to establish the reorganization of the structural components of the liver under the conditions of simulated HHCy, hyper- and hypothyroidism and their combined effects.

Materials and Methods. Thiolactone HHCy was simulated by administering to animals exogenous HC in the form of thiolactone at a dose of 100 mg/kg body weight once a day for 28 days. Hyperthyroidism was simulated by daily administration of L-thyroxine at a dose of 200 μg/kg on day 21, hypothyroidism – daily administration of mercazolyl at a dose of 10 mg/kg on day 21. Separate groups of animals were administered L-thyroxine and mercazolyl in parallel with HC.

Results. It was found that under the conditions of simulated HHCy, hypo- and hyperthyroidism in the liver of experimental animals there are disorders of microcirculation, which at the submicroscopic level were manifested by sludge-phenomenon, stasis of blood cells in dilated lumens of sinusoids, damage of the endothelial cells ultrastructure, of some endoplasmic reticulum tubules, vacuoles and dilated cysterns of the Golgi complex, mitochondria were solitary with homogeneous, light matrix and lysed crystae, Disse spaces were mostly expanded, they had Kupffer cells, cytoplasm of sinusoid endothelial cells was enlightened, swollen and destructively changed, and the blood cells and vacuole-like structures were present in the lumen of sinusoids.

Conclusions. Both HHCy and hypo- or hyperthyroidism separately and especially under the conditions of their synergistic action caused the presence of “light” and “dark” hepatocytes in the liver lobules, as a manifestation of adaptive-compensatory, destructive and development of necrotic changes in the body. Irreversible damage to the components of the nuclei and organelles of hepatocytes develops, which leads to disruption of synthetic, energetic and detoxification processes in cells and, consequently, in the organs.

References

Ai Y, Sun Z, Peng C, Liu L, Xiao X, Li J. Homocysteine induces hepatic steatosis involving ER stress response in high methionine diet-fed mice. Nutrients. 2017;9(4): 346. DOI: 10.3390/nu9040346. PMID: 28368295; PMCID: PMC5409685.

Al Mutairi F. Hyperhomocysteinemia: Clinical insights. J Cent Nerv Syst Dis. 2020;12: 1179573520962230. DOI: 10.1177/1179573520962230. PMID: 33100834; PMCID: PMC7549175.

Azzini E, Ruggeri S, Polito A. Homocysteine: Its possible emerging role in at-risk population groups. Int J Mol Sci. 2020;21(4): 1421. DOI: 10.3390/ijms21041421. PMID: 32093165; PMCID: PMC7073042.

Chi HC, Tsai CY, Tsai MM, Yeh CT, Lin KH. Molecular functions and clinical impact of thyroid hormone-triggered autophagy in liver-related diseases. J Biomed Sci. 2019;26(1): 24. DOI: 10.1186/s12929-019-0517-x. PMID: 30849993; PMCID: PMC6407245.

Dong X, Yao Z, Hu Y, Yang N, Gao X, Xu Y, Wang G. Potential harmful correlation between homocysteine and low-density lipoprotein cholesterol in patients with hypothyroidism. Medicine (Baltimore). 2016;95(29): e4291. DOI: 10.1097/MD.0000000000004291. PMID: 27442671; PMCID: PMC5265788.

García-Tevijano ER, Berasain C, Rodríguez JA, Corrales FJ, Arias R, Martín-Duce A, Caballería J, Mato JM, Avila MA. Hyperhomocysteinemia in liver cirrhosis: mechanisms and role in vascular and hepatic fibrosis. Hypertension. 2001;38(5): 1217-21. DOI: 10.1161/hy1101.099499. PMID: 11711526.

Gauthier BR, Sola-García A, Cáliz-Molina MÁ, Lorenzo PI, Cobo-Vuilleumier N, Capilla-González V, Martin-Montalvo A. Thyroid hormones in diabetes, cancer, and aging. Aging Cell. 2020;19(11): e13260. DOI: 10.1111/acel.13260. Epub 2020 Oct 13. PMID: 33048427; PMCID: PMC7681062.

Goralskiy LP, Homich VТ, Kononskiy ОІ. Fundamentals of histological technique and morphofunctional methods of research in norm and in pathology. [Основи гістологічної техніки і морфофункціональні методи досліджень у нормі та при патології] Zhytomyr: Polissia; 2011. Ukrainian.

Hsieh A, Adelstein S, McLennan SV, Williams PF, Chua EL, Twigg SM. Liver enzyme profile and progression in association with thyroid autoimmunity in Graves' disease. Endocrinol Diabetes Metab. 2019;2(4): e00086. DOI: 10.1002/edm2.86. PMID: 31592447; PMCID: PMC6775470.

Huang G, Ueda M, Tasaki M, Yamashita T, Misumi Y, Masuda T, Suenaga G, Inoue Y, Kinoshita Y, Matsumoto S, Mizukami M, Tsuda Y, Nomura T, Obayashi K, Ando Y. Clinicopathological and biochemical findings of thyroid amyloid in hereditary transthyretin amyloidosis with and without liver transplantation. Amyloid. 2017;24(1): 24-9. DOI: 10.1080/13506129.2016.1276440. Epub 2017 Jan 13. PMID: 28081656.

Kalra S, Aggarwal S, Khandelwal D. Thyroid dysfunction and dysmetabolic syndrome: The need for enhanced thyrovigilance strategies. Int J Endocrinol. 2021;29;2021: 9641846. DOI: 10.1155/2021/9641846. PMID: 33859689; PMCID: PMC8024090.

Larsson SC, Traylor M, Markus HS. Homocysteine and small vessel stroke: A mendelian randomization analysis. Ann Neurol. 2019;85(4): 495-501. DOI: 10.1002/ana.25440. Epub 2019 Mar 11. PMID: 30785218; PMCID: PMC6594149.

Latteri S, Malaguarnera G, Catania VE, La Greca G, Bertino G, Borzì AM, Drago F, Malaguarnera M. Homocysteine serum levels as prognostic marker of hepatocellular carcinoma with portal vein thrombosis. Curr Mol Med. 2019;19(7): 532-8. DOI: 10.2174/1566524019666190610120416. PMID: 31187711.

Lin YH, Lin KH, Yeh CT. Thyroid hormone in hepatocellular carcinoma: Cancer risk, growth regulation, and anticancer drug resistance. Front Med (Lausanne). 2020;7: 174. DOI: 10.3389/fmed.2020.00174. PMID: 32528965; PMCID: PMC7258858.

Nechiporuk V, Zaichko N, Korda М, Melnyk A, Koloshko O. Sulphur-containing amino acids metabolism in experimental hyper- and hypothyroidism in rats. Georgian Med News. 2017;(271): 96-102. PMID: 29099709.

Nechyporuk V, Korda M, Kovalchuk O. Morphological changes of the liver under conditions of hyperhomocysteinemia in the background of hypo- and hyperthyroidism. Reports of Morphology [Internet]. 2020;26(2): 19-25. Available from: https://morphology-journal.com/index.php/journal/article/view/416.

Nechyporuk VM, Korda MM. Metabolism of cysteine in experimental hyper- and hypothyroidism in rats. MCCh [Internet]. 2018;11(4): 32-40. Available from: https://ojs.tdmu.edu.ua/index.php/MCC/article/view/8433.

Netyazhenko V, Liakhotska A. Thyroid dysfunction and cardiovascular diseases: problem and ways to solve it. Mìžnarodnij endokrinologìčnij žurnal [Internet]. 2020;16(4): 333-6. Available from: http://iej.zaslavsky.com.ua/article/view/208487

Pacana T, Cazanave S, Verdianelli A, Patel V, Min HK, Mirshahi F, Quinlivan E, Sanyal AJ. Dysregulated hepatic methionine metabolism drives homocysteine elevation in diet-induced nonalcoholic fatty liver disease. PLoS One. 2015;31;10(8): e0136822. DOI: 10.1371/journal.pone.0136822. PMID: 26322888; PMCID: PMC4556375.

Punekar P, Sharma AK, Jain A. A study of thyroid dysfunction in cirrhosis of liver and correlation with severity of liver disease. Indian J Endocrinol Metab. 2018;22(5): 645-50. DOI: 10.4103/ijem.IJEM_25_18. PMID: 30294575; PMCID: PMC6166553.

Selicharová I, Kořínek M, Demianová Z, Chrudinová M, Mládková J, Jiráček J. Effects of hyperhomocysteinemia and betaine-homocysteine S-methyltransferase inhibition on hepatocyte metabolites and the proteome. Biochim Biophys Acta. 2013;1834(8): 1596-606. DOI: 10.1016/j.bbapap.2013.05.009. Epub 2013 May 18. PMID: 23689031.

Stangl GI, Weisse K, Dinger C, Hirche F, Brandsch C, Eder K. Homocysteine thiolactone-induced hyperhomocysteinemia does not alter concentrations of cholesterol and SREBP-2 target gene mRNAS in rats. Exp Biol Med (Maywood). 2007;232(1): 81-7. PMID: 17202588.

Tanase DM, Gosav EM, Neculae E, Costea CF, Ciocoiu M, Hurjui LL, Tarniceriu CC, Floria M. Hypothyroidism-induced nonalcoholic fatty liver disease (HIN): Mechanisms and emerging therapeutic options. Int J Mol Sci. 2020;21(16): 5927. DOI: 10.3390/ijms21165927. PMID: 32824723; PMCID: PMC7460638.

Teixeira PFDS, Dos Santos PB, Pazos-Moura CC. The role of thyroid hormone in metabolism and metabolic syndrome. Ther Adv Endocrinol Metab. 2020;11: 2042018820917869. DOI: 10.1177/2042018820917869. PMID: 32489580; PMCID: PMC7238803.

Vincken S, Reynaert H, Schiettecatte J, Kaufman L, Velkeniers B. Liver cirrhosis and thyroid function: Friend or foe? Acta Clin Belg. 2017;72(2): 85-90. DOI: 10.1080/17843286.2016.1215641. Epub 2016 Aug 24. PMID: 27553585.

Wang R, Tan J, Zhang G, Zheng W, Li C. Risk factors of hepatic dysfunction in patients with Graves' hyperthyroidism and the efficacy of 131iodine treatment. Medicine (Baltimore). 2017;96(5): e6035. DOI: 10.1097/MD.0000000000006035. PMID: 28151911; PMCID: PMC5293474.

Yu X, Lv J, Zhu Y, Duan L, Ma L. Homocysteine inhibits hepatocyte proliferation via endoplasmic reticulum stress. PLoS One. 2013;8(1): e54265. DOI: 10.1371/journal.pone.0054265. Epub 2013 Jan 22. PMID: 23349842; PMCID: PMC3551933.

Zhang D, Lou J, Zhang X, Zhang L, Wang F, Xu D, Niu N, Wang Y, Wu Y, Cui W. Hyperhomocysteinemia results from and promotes hepatocellular carcinoma via CYP450 metabolism by CYP2J2 DNA methylation. Oncotarget. 2017;8(9): 15377-92. DOI: 10.18632/oncotarget.14165. PMID: 28030819; PMCID: PMC5362492.

Zhang D, Wen X, Wu W, Guo Y, Cui W. Elevated homocysteine level and folate deficiency associated with increased overall risk of carcinogenesis: meta-analysis of 83 case-control studies involving 35,758 individuals. PloS one. 2015;810: e01234

Published

2021-09-02

How to Cite

Nechiporuk, V. M., Nebesna, Z. M., Kovalchuk О. V., Pentiuk, L. O., & Korda, M. M. (2021). ULTRASTRUCTURAL CHANGES IN THE LIVER IN EXPERIMENTAL HYPERHOMOCYSTEINEMIA ON THE BACKGROUND OF HYPO- AND HYPERTHYROIDISM. Bulletin of Medical and Biological Research, (2), 51–60. https://doi.org/10.11603/bmbr.2706-6290.2021.2.12339